Session Details
[SY2]Symposium 2 : Control of endemic HTLV-1 to prevent silent global spread
Mon. Nov 2, 2026 9:15 AM - 11:30 AM JST
Mon. Nov 2, 2026 12:15 AM - 2:30 AM UTC
Mon. Nov 2, 2026 12:15 AM - 2:30 AM UTC
Room 2 (2F Room 201)
Chair: Tetsuro Matano (National Institute of Infectious Diseases, Japan Institute for Health Security )
Damian Purcell (Department of Microbiology and Immunology at the Doherty Institute, University of Melbourne, Australia)
Damian Purcell (Department of Microbiology and Immunology at the Doherty Institute, University of Melbourne, Australia)
Overview of AU-JP ASPIRE HTLV project
[SY2-1]HTLV-1c associated morbidity and mortality in Australia
*Lloyd Einsiedel1 (1. Department of microbiology and immunology, University of Melbourne, Australia)
[SY2-2]HTLV-1 Infection in Japan and Australia: Virological Insights into Viral Diversity and Pathogenesis
Sharmin Nahar Sithi1,2, Kazuki Matsuyama2, Kenji Sugata1,2, Sachiho Kawahara3, Naho Ninomiya2, Ishrat M Jahan1,2, Md Samiul Alam Rajib1, Natasha Jansz4, Ashley Hirons4, Damian FJ Purcell4, *Yorifumi Satou1,2 (1. Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, 2. Joint Research Center for Human Retrovirus Infection, Kumamoto University, 3. Graduate School of Medicine, Hokkaido University, 4. Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne)
[SY2-3]Australian HTLV-1c has distinctive virology and immunopathogenesis relative to HTLV-1a from Japan, but common opportunities to prevent infection and disease.
*Damian Purcell1 (1. Department of Microbiology and Immunology at the Doherty Institute, University of Melbourne, Australia)
[SY2-4]Integrated genomic and epigenomic analysis for therapeutic target discovery in HTLV-1-associated diseases
*Makoto Yamagishi1 (1. Graduate School of Frontier Sciences, University of Tokyo)